TLR4: The receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines

Immunology and Cell Biology

Volumn 88, Issue 5, 2010, Pages 529-536

  Ren, Meiyu ^a   Gao, Li ^a   Wu, Xinyi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Acanthamoeba; corneal epithelium; corneal stroma; keratitis; Toll like receptor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BETA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; PYRROLIDINE DITHIOCARBAMATE; TELOMERASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; TLR4 PROTEIN, HUMAN;

ACANTHAMOEBA; ACANTHAMOEBA INFECTION; ARTICLE; CELL IMMORTALIZATION; CELL LINE; CORNEA EPITHELIUM; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ACANTHAMOEBA KERATITIS; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; BLOTTING, WESTERN; CELL LINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM, CORNEAL; HUMANS; INFLAMMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

ACANTHAMOEBA; PROTOZOA;

EID: 77954309960     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.6     Document Type: Article

References (54)

1. Jones DB, Visvesvara GS, Robinson NM. Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc UK 1975; 95: 221-232.
2. Seal DV, Beattie TK, Tomlinson A, Fan D, Wong E. Acanthamoeba keratitis. Br J Ophthalmol 2003; 87: 516-517.
3. Bharathi MJ, Srinivasan M, Ramakrishnan R, Meenakshi R, Padmacathy S, Lalitha PN. A study of the spectrum of AK: a three-year study at a tertiary eye care referral center in South India. Indian J Ophthalmol 2007; 55: 37-42.
4. Zhang WH, Pan ZQ, Wang ZQ, Jin XY, Luo SY, Zou Y et al. The variance of pathogenic organisms of purulent ulcerative keratitis. Zhonghua Yan Ke Za Zhi 2002; 38: 1:8-112.
5. Li CP, Wang J. Preliminary survey of Acanthamoeba keratitis in Huainan areas. J Fourth Military Med Univ (Chin) 2003; 24: 86-88.
6. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 2006; 17: 327-331.
7. Radford CF, Minassian DC, Dart JK. AK in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 2002; 86: 536-542.
8. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
9. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499-511.
10. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003; 85: 85-95.
11. Proost P, Vynckier AK, Mahieu F. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 2003; 33: 3146-3153.
12. Zhande R, Dauphinee SM, Thomas JA, Yamamoto M, Akira S, Karsan A. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction. Mol Cell Biol 2007; 27: 7394-7404.
13. Yu FS, Hazlett LD. Toll-like receptors and the eye. Invest Ophthalmol Vis Sci 2006; 47: 1255-1263.
14. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169: 6668-6672.
15. Niederkorn JY, Alizadeh H, Leher H, McCulley JP. The pathogenesis of Acanthamoeba keratitis. Microbes Infect 1999; 1: 437-443.
16. Clarke DW, Niederkorn JY. The immunobiology of Acanthamoeba keratitis. Microbes Infect 2006; 8: 1400-1405.
17. Campos MA, Gazzinelli RT. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors. Mediators Inflamm 2004; 13: 139-143.
18. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787.
19. Clarke DW, Niederkorn JY. The immunobiology of Acanthamoeba keratitis. Microbes Infect 2006; 8: 1400-1405.
20. Garate M, Marchant J, Cubillos I, Cao ZY, Kban NA, Panjwani N. In vitro pathogeneicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Invest Ophthalmol Vis Sc 2006; 47: 1056-1062.
21. Imbert-Bouyer S, Merlaud A, Imbert C, Daniault G, Rodier MH. A mannose binding protein is involved in the adherence of Acanthamoeba species to inert surfaces. FEMS Microbiol Lett 2004; 238: 207-211.
22. Garate M, Cao Z, Bateman E, Panjwani N. Cloning and characterization of a novel mannose-binding protein of Acanthamoeba. J Biol Chem 2004; 279: 29849-29856.
23. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive cell wall components. Immunity 1999; 11: 443-451.
24. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 1999; 274: 17406-17409.
25. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M et al. The Tolllike receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401: 811-815.
26. Coelho PS, Klein A, Talvani A, Coutinho SF, Takeuchi O, Akira S et al. Glycosylpho-sphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-g-primed-macrophages. J Leukoc Biol 2002; 71: 837-844.
27. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE et al. Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277: 15028-15034.
28. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
29. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1: 398-401.
30. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276: 10229-10233.
31. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233-5239.
32. Zhang J, Xu K, Ambati B, Yu FS. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthamol Vis Sci 2003; 44: 4247-4254.
33. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009; 284: 24035-24048.
34. Ueta M, Nochi T, Jang MH, Park EJ, Igarashi O, Hino A et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol 2004; 173: 3337-3347.
35. Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol 2006; 90: 103-108.
36. Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, Nishida T. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest Ophthalmol Vis Sci 2005; 46: 114-120.
37. Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol 2003; 121: 653-656.
38. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000; 164: 3476-3479. (Pubitemid 30169796)
39. Terlikowski SJ. Tumour necrosis factor and cancer treatment: a historical review and perspectives. Rocz Akad Med Bialymst 2001; 46: 5-18.
40. Vlahopoulos S, Boldogh I, Casola A, Brasier AR. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999; 94: 1878-1889.
41. Watanabe Y. Fifty years of interference. Nat Immunol 2004; 5: 1193.
42. Takaoka A, Hayakawa S, Yanai H. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003; 424: 516-523.
43. Triantafilou K, Triantafilou M. Coxsachievirus B4 induced cytokine production in pancreatic cells is mediated through Toll-like receptor 4. J Virol 2004; 78: 11313-11320.
44. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003; 77: 4588-4596.
45. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP et al. Hemagglutinin protein of wild-type measles virus activate toll-like receptor 2 signaling. J Virol 2002; 76: 8729-8736.
46. Kurt-Jones EA, Chan M, Zhou S. Herpes simplex virus 1 interaction with Toll-like receptor2 contribute to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101: 1315-1320.
47. Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M, Mor F, Carmi P, Zanin-Zhorov A et al. Heat shock protein 60 activate B cells via the TLR4-MyD88 pathway. J Immunol 2005; 175: 3594-3601.
48. Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. Changes in Toll-like receptor(TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest Ophthalmol Vis Sci 2007; 48: 1711-1717.
49. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL et al. MyD88: an adapter protein involved in interleukin-1 signaling. J Bio Chem 1998; 273: 12203-12209.
50. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T et al. TRAM is specifically involved in the Toll-like receptor 4\mediated MyD88\independent signaling pathway. Nat Immunol 2003; 4: 1144-1150.
51. Dziarske R, Jin YP, Gupta D. Differential activation of extracellular signal-regulated kinase (ERK1/2)1, ERK1/22, p38 and c-Jun N-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J Infect Dis 1996; 174: 777-785.
52. de Mos M, Laferrière A, Millecamps M, Pilkington M, Sturkenboom MC, Huygen FJ et al. Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I). J Pain 2009; 10: 1161-1169.
53. Rice PL, Beard KS, Driggers LJ, Ahnen DJ. Inhibition of extracellular-signal regulated kinases1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites. Cancer Res 2004; 64: 8148-8151.
54. Zhang Y, Sun XG, Deng SJ et al. Molecular characteristics of Acanthamoeba strains from keratitis patients. Zhonghua Yan Ke Za Zhi 2004; 40: 389-394.